Cargando…

The Effect of the Angiotensin-Converting Enzyme Inhibitor on Bone Health in Castrated Hypertensive Rats Is Mediated via the Kinin-Kallikrein System

BACKGROUND: In previous studies, angiotensin-converting enzyme inhibitor (ACEI) use was associated with increased bone loss, while an angiotensin II type I receptor blocker had no effect on bone loss in elder subjects, which suggested that the effect of ACEI on bone loss was not mediated through the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Na, Huo, Yanan, Yao, Chen, Sun, Jie, Zhang, Yafeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213206/ https://www.ncbi.nlm.nih.gov/pubmed/35814865 http://dx.doi.org/10.1155/2022/9067167

Ejemplares similares

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS
por: Manoharan, Sivananthan, et al.
Publicado: (2017)

The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection
por: Carvalho, Patricia Ribeiro de, et al.
Publicado: (2021)

Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
por: Bekassy, Zivile, et al.
Publicado: (2021)

The kallikrein-kinin system in diabetic nephropathy
por: Tomita, Hirofumi, et al.
Publicado: (2012)

Kallikrein–kinin system: is it the fountain of youth?
por: Garaffa, Giulio, et al.
Publicado: (2017)

An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro Studies
por: Ceravolo, Graziela S., et al.
Publicado: (2014)

A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin–Angiotensin Systems
por: Schmaier, Alvin H.
Publicado: (2016)

Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads
por: Hoevenaar, Martijn, et al.
Publicado: (2020)

Role of the kallikrein–kinin system in traumatic brain injury
por: Albert-Weissenberger, Christiane, et al.
Publicado: (2014)

Lack of Plasma Kallikrein-Kinin System Cascade in Teleosts
por: Wong, Marty Kwok-Shing, et al.
Publicado: (2013)

Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
por: Cooper, Samantha L., et al.
Publicado: (2021)

Danhong injection reduces vascular remodeling and up-regulates the Kallikrein-kinin system in spontaneously hypertensive rats
por: Yang, Xiaohu, et al.
Publicado: (2017)

Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on‐demand treatment of hereditary angioedema
por: Duckworth, Edward J., et al.
Publicado: (2022)

Interaction of Bacteroides fragilis and Bacteroides thetaiotaomicron with the kallikrein–kinin system
por: Murphy, Elizabeth C., et al.
Publicado: (2011)

Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
por: Alfaro, Enrique, et al.
Publicado: (2022)

In vitro reconstitution of kallikrein-kinin system and progress curve analysis
por: Favier, Bertrand, et al.
Publicado: (2022)

Editorial: Kallikrein-kinin system: insights into a multifunctional system
por: Motta, Guacyara, et al.
Publicado: (2023)

Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy
por: Oliveira, Lilian Caroline Gonçalves, et al.
Publicado: (2021)

Differences in the expression of the renin angiotensin system and the kallikrein-kinin system during the course of myocardial infarction in male and female Wistar rats
por: Flores-Monroy, Jazmín, et al.
Publicado: (2020)

A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients
por: Gouda, Ahmed S., et al.
Publicado: (2021)

COVID-19 and Lung Mast Cells: The Kallikrein–Kinin Activation Pathway
por: Nagashima, Seigo, et al.
Publicado: (2022)

Alterations in the kallikrein-kinin system predict death after heart transplant
por: Giangreco, Nicholas P., et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Inhibitor, Captopril, Improves Scar Healing in Hypertensive Rats
por: Rha, Eun Young, et al.
Publicado: (2021)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitor Protects Against Cisplatin Nephrotoxicity by Modulating Kinin B1 Receptor Expression and Aminopeptidase P Activity in Mice
por: Estrela, Gabriel R., et al.
Publicado: (2020)

AB097. The expression of kallikrein-kinin system in penile tissue of ED rat model
por: Amuti, Siyiti, et al.
Publicado: (2018)

Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems
por: Fang, Chao, et al.
Publicado: (2020)

SARS-CoV-2 receptor is co-expressed with elements of the kinin–kallikrein, renin–angiotensin and coagulation systems in alveolar cells
por: Sidarta-Oliveira, Davi, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?
por: Turner, Jeffrey M., et al.
Publicado: (2020)

The kallikrein-kinin system: a promising therapeutic target for traumatic brain injury
por: Hopp, Sarah, et al.
Publicado: (2015)

Genetic Variation of Kallikrein-Kinin System and Related Genes in Patients With Hereditary Angioedema
por: Veronez, Camila Lopes, et al.
Publicado: (2019)

Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans
por: Motta, Guacyara, et al.
Publicado: (2017)

Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
por: Lopatko Fagerström, Ingrid, et al.
Publicado: (2019)

The relationship between clinical phenotype and kallikrein-kinin bioregulation in different forms of arthritis
por: Tan, Dino B. A., et al.
Publicado: (2023)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

Aliskiren – an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension
por: Zaporowska-Stachowiak, Iwona, et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Sexual Dimorphism in the Expression of Cardiac and Hippocampal Renin-Angiotensin and Kallikrein–Kinin Systems in Offspring from Mice Exposed to Alcohol during Gestation
por: da Silva, Gabriel Almeida, et al.
Publicado: (2023)

Assessment of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker on the split renal function in the patients with primary hypertension
por: Zhang, Jingsi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0go48db1if1uip4j9qjba91a7m